In the Fall of 2021, the Foundation convened a summit to discuss accelerating enrollment into clinical trials. Patients, healthcare professionals, representatives from other non-profits, the pharmaceutical industry, and the Food & Drug Administration (FDA) participated in discussion...

Finding a treatment that works to treat IBD patients’ symptoms and help induce remission is important. But these treatments wouldn’t be available without clinical trials. In fact, every single IBD medicine currently available on the market is primarily there because of clinical trials a...

Up to one-third of ulcerative colitis patients may require surgery because of their disease. The most commonly performed surgery is a proctocolectomy with ileal pouch-anal anastomosis, commonly known as a j-pouch. Over the course of one, two, or three surgeries, the colon and rectum are...

Initial results from two important ulcerative colitis clinical trials were recently released, suggesting that a new treatment option for IBD may receive FDA approval soon. These results have been eagerly awaited by the IBD research community as an important step in advancing a long-term...

If you’ve been following the Crohn’s & Colitis Foundation, you know they've been busy making innovative changes to their research approach. They have been working to improve the way IBD clinical care is delivered through IBD Qorus, which is designed to bring patients and providers f...

The Crohn's & Colitis Foundation and RTI International are working together to conduct a survey of adult patients and caregivers of pediatric patients with inflammatory bowel disease. The goal of this survey is to understand why some patients choose to participate in clinical trials...

Each May, Clinical Trials Day is observed to raise awareness of clinical trials and honor research professionals for their commitment and contributions to public health and medical progress. Without clinical trials, we wouldn't have medications available to treat IBD. That's why patient...

Clinical trials play a key role in the development and approval of new treatment options for IBD patients. In order to understand patient perceptions and improve recruitment, the Crohn's & Colitis Foundation conducted in-person focus groups over a four-month period in 2016, the resu...